DMAA
Drugs Made In America Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$10.87
+0.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 55.37x
- PEG TTM
- —
- Price / book
- 1.92x
- Price / sales
- —
- Price / cash flow
- -816.67x
Enterprise value
- Enterprise value
- $264.8M
- EV / sales
- —
- EV / EBITDA
- -100.56x
- EV / EBIT
- -100.56x
- Market cap
- $263.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026